Witnessing the stock’s movement on the chart, on Wednesday, Johnson & Johnson (NYSE: JNJ) set off with pace as it heaved 0.29% to $194.39, before settling in for the price of $193.83 at the close. Taking a more long-term approach, JNJ posted a 52-week range of $140.68-$194.48.
The Healthcare sector firm’s twelve-monthly sales growth has been 0.55% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 0.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.86%. This publicly-traded company’s shares outstanding now amounts to $2.41 billion, simultaneously with a float of $2.41 billion. The organization now has a market capitalization sitting at $468.34 billion. At the time of writing, stock’s 50-day Moving Average stood at $185.16, while the 200-day Moving Average is $166.41.
Johnson & Johnson (JNJ) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – General industry. Johnson & Johnson’s current insider ownership accounts for 0.14%, in contrast to 73.65% institutional ownership. According to the most recent insider trade that took place on Nov 06 ’25, this organization’s 10% Owner sold 52,332 shares at the rate of 10.21, making the entire transaction reach 534,310 in total value, affecting insider ownership by 4,051,098. Preceding that transaction, on Nov 07 ’25, Company’s 10% Owner sold 200 for 10.00, making the whole transaction’s value amount to 2,000. This particular insider is now the holder of 4,050,898 in total.
Johnson & Johnson (JNJ) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.75 per share during the current fiscal year.
Johnson & Johnson’s EPS increase for this current 12-month fiscal period is 8.86% and is forecasted to reach 11.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.45% through the next 5 years, which can be compared against the 0.55% growth it accomplished over the previous five years trading on the market.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Let’s observe the current performance indicators for Johnson & Johnson (JNJ). It’s Quick Ratio in the last reported quarter now stands at 0.80. Alongside those numbers, its PE Ratio stands at $18.76, and its Beta score is 0.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.08. Similarly, its price to free cash flow for trailing twelve months is now 23.90.
In the same vein, JNJ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 10.36, a figure that is expected to reach 2.53 in the next quarter, and analysts are predicting that it will be 11.51 at the market close of one year from today.
Technical Analysis of Johnson & Johnson (JNJ)
Going through the that latest performance of [Johnson & Johnson, JNJ]. Its last 5-days volume of 7.06 million was inferior to the volume of 8.82 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 88.46% While, its Average True Range was 70.86.
Raw Stochastic average of Johnson & Johnson (JNJ) in the period of the previous 100 days is set at 97.42%, which indicates a major rise in contrast to 89.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.73 that was higher than 2.54 volatility it exhibited in the past 100-days period.
